Skip to main content

Mandrake Bio

Mandrake Bio

Type

Startup

Founded

2025

Funding captured

$1.7m

Deals captured

1

About Mandrake Bio

Mandrake Bio is a full-stack protein-design company developing molecular machinery for next-generation gene editing. It uses sequence- and structure-aware AI models informed by biological and biophysical requirements, then validates designed proteins through custom assays in its wet lab and partner network. Its applications include tissue-culture-free editing of elite crops and gene editors designed for more accessible genetic medicines.

Mandrake Bio funding captured (1)

Deal typeStageDateAmountInvestors
EquityPre-SeedJul 16, 2026$1.7m